The Merger and Acquisition in the Blood Products Sector after Covid-19: A Study on the Deals of China’s Enterprises
After COVID-19, the demand for blood products such as IVIG roared up immediately. Global biopharmaceutical enterprises are in a wave of M&As for expansion. While there lacks of related research on China’s blood products sector. This article takes the example of financial data from Grifols and Ch...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2024-01-01
|
Series: | SHS Web of Conferences |
Online Access: | https://www.shs-conferences.org/articles/shsconf/pdf/2024/27/shsconf_icdeba2024_01024.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|